Community walking can be assessed using a 10-metre timed walk test

Multiple Sclerosis Journal

Volumn 17, Issue 8, 2011, Pages 980-990

  Kempen, Jce ^a,b   De Groot, V ^a,b   Knol, D L ^a   Polman, C H ^a,b   Lankhorst, G J ^a   Beckerman, H ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MS Center Amsterdam   (Netherlands)

Author keywords

10 metre timed walk test; EDSS; minimally important change; multiple sclerosis; ROC curve; walking

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ASSESSMENT; COMMUNITY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY IMPORTANT CHANGE; MODIFIED FUNCTIONAL WALKING CATEGORY; MULTIPLE SCLEROSIS; RATING SCALE; VELOCITY; WALKING SPEED;

EID: 80051958078     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511403641     Document Type: Article

References (49)

1. Vaney C, Vaney S, Wade DT. SaGAS, the Short and Graphic Ability Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional Composite. Mult Scler. 2004 ; 10: 231-242 (Pubitemid 38499918)
2. Pearson OR, Busse ME, van Deursen RWM, Wiles CM. Quantification of walking mobility in neurological disorders. QJM. 2004 ; 97: 463-475 (Pubitemid 39144594)
3. Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler. 2006 ; 12: 620-628 (Pubitemid 46947926)
4. Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, et al. The measurement of ambulatory impairment in multiple sclerosis. Neurology. 1997 ; 49: 1419-1424 (Pubitemid 27495653)
5. Albrecht H, Wotzel C, Erasmus LP, Kleinpeter M, Konig N, Pollmann W. Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter. Mult Scler. 2001 ; 7: 105-109 (Pubitemid 32514525)
6. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008 ; 14: 383-390 (Pubitemid 351676433)
7. Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke. 1995 ; 26: 982-989
8. Lord SE, McPherson K, McNaughton HK, Rochester L, Weatherall M. Community ambulation after stroke: how important and obtainable is it and what measures appear predictive?. Arch Phys Med Rehabil. 2004 ; 85: 234-239 (Pubitemid 38182566)
9. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, et al. Intensive immunosuppression in progressive multiple sclerosis: A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983 ; 308: 173-180 (Pubitemid 13171135)
10. Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change?. Neurology. 2002 ; 58: 1294-1296 (Pubitemid 34411881)
11. Vaney C, Blaurock H, Gattlen B, Meisels C. Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed. Clin Rehabil. 1996 ; 10: 216-226 (Pubitemid 26241676)
12. Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 1997 ; 48: 817-821
13. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999 ; 122: 141-159 (Pubitemid 29046280)
14. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology. 2003 ; 60: 31-36 (Pubitemid 36070640)
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
16. Lernier-Frankiel M, Vargas S, Brown M, Krusell L, Schoneberger W. Functional community ambulation: What are your criteria?. Clin Manag. 1986 ; 6: 12-15
17. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999 ; 122: 871-882 (Pubitemid 29219261)
18. McGinley J. Criteria for community ambulation: Implications for stroke rehabilitation. Abstract from Australian Physiotherapy Association (Vic) Neurology Research Forum, Melbourne. Neurology. 1992 ; 3 :
19. Lord SE, Rochester L. Measurement of community ambulation after stroke: current status and future developments. Stroke. 2005 ; 36: 1457-1461 (Pubitemid 40967512)
20. Schmid A, Duncan PW, Studenski S, Lai SM, Richards L, Perera S, et al. Improvements in speed-based gait classifications are meaningful. Stroke. 2007 ; 38: 2096-2100 (Pubitemid 47012274)
21. Holden MK, Gill KM, Magliozzi MR. Gait assessment for neurologically impaired patients. Standards for outcome assessment. Phys Ther. 1986 ; 66: 1530-1539 (Pubitemid 16002400)
22. Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke. Arch Phys Med Rehabil. 2007 ; 88: 1314-1319 (Pubitemid 47483651)
23. de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM. The initial course of daily functioning in multiple sclerosis: a three-year follow-up study. Mult Scler. 2005 ; 11: 713-718 (Pubitemid 41685144)
24. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231 (Pubitemid 13158528)
25. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 ; 64: 35-40 (Pubitemid 14219736)
26. Lim LIIK, van Wegen EEH, de Goede CJT, Jones D, Rochester L, Hetherington V, et al. Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord. 2005 ; 11: 19-24 (Pubitemid 40037593)
27. Green J, Forster A, Young J. Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clin Rehabil. 2002 ; 16: 306-314 (Pubitemid 34467222)
28. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993 ; 39: 561-577 (Pubitemid 23118304)
29. Altman DG. Practical statistics for medical research. 1999.
30. van der Windt DA, van der Heijden GJ, de Winter AF, Koes BW, Deville W, Bouter LM. The responsiveness of the Shoulder Disability Questionnaire. Ann Rheum Dis. 1998 ; 57: 82-87 (Pubitemid 28177536)
31. Beurskens AJ, de Vet HC, Koke AJ. Responsiveness of functional status in low back pain: a comparison of different instruments. Pain. 1996 ; 65: 71-76 (Pubitemid 26227690)
32. de Vet HCW, Ostelo RWJG, Terwee CB, van der Roer N, Knol DL, Beckerman H, et al. Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res. 2007 ; 16: 131-142 (Pubitemid 46046743)
33. de Groot V, Beckerman H, Uitdehaag BM, de Vet HC, Lankhorst GJ, Polman CH, et al. The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain. 2006 ; 129: 2648-2659 (Pubitemid 44522098)
34. Chow SC. Encyclopedia of biopharmaceutical statistics. 2003.
35. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics. 1997 ; 53: 567-578 (Pubitemid 27262219)
36. Wang F, Gatsonis CA. Hierarchical models for ROC curve summary measures: design and analysis of multi-reader, multi-modality studies of medical tests. Stat Med. 2008 ; 27: 243-256 (Pubitemid 351193650)
37. Goodkin DE, Cookfair D, Wende K, Bourdette D, Pullicino P, Scherokman B, et al. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology. 1992 ; 42: 859-863
38. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial: The Canadian Cooperation MS Study Group. Neurology. 1990 ; 40: 971-975 (Pubitemid 20201827)
39. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials. 1991 ; 12(Suppl. 4): 142 S - 58 S
40. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000 ; 53: 459-468 (Pubitemid 30254341)
41. Daamen W, Hoogendoorn SP Pedestrian and evacuation dynamics. Gales ER, ed. London: CMS Press ; 2003: 121-132.
42. van der Port IG, Kwakkel G and Lindeman E. Community ambulation in patients with chronic stroke: how is it related to gait speed? J Rehabil Med 2008; 40: 23-27. (Pubitemid 351200729)
43. Kollen B, Kwakkel G, Lindeman E. Hemiplegic gait after stroke: is measurement of maximum speed required?. Arch Phys Med Rehabil. 2006 ; 87: 358-363 (Pubitemid 43286944)
44. Bohannon RW. Walking after stroke: comfortable versus maximum safe speed. Int J Rehabil Res. 1992 ; 15: 246-248
45. Blue VJ, Adler JL. Cellular automata microsimulation for modeling bi-directional pedestrian walkways. Transp Res, Part B, Methodol. 2001 ; 35: 293-312
46. Paltamaa J, Sarasoja T, Leskinen E, Wikstrom J, Malkia E. Measuring deterioration in international classification of functioning domains of people with multiple sclerosis who are ambulatory. Phys Ther. 2008 ; 88: 176-190 (Pubitemid 351196711)
47. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler. 2000 ; 6: 286-290
48. Nilsagard Y, Lundholm C, Gunnarsson LG, Dcnison E. Clinical relevance using timed walk tests and 'timed up and go' testing in persons with multiple sclerosis. Physiother Res Int. 2007 ; 12: 105-114
49. Oberg T, Karsznia A, Oberg K. Basic gait parameters: reference data for normal subjects, 10-79 years of age. J Rehabil Res Dev. 1993 ; 30: 210-223 (Pubitemid 24030997)